# Deferasirox

NDC: 62332-324
Generic name: Deferasirox
Labeler / Manufacturer: Alembic Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20191121

FDA application: ANDA210060

## Active ingredients

- DEFERASIROX: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62332-324"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62332-324
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1f9f1a69-bf71-4e6a-88b0-90f08c4da79f